155 related articles for article (PubMed ID: 1901332)
1. In vivo interferon-gamma therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae.
Rex JH; Bennett JE; Gallin JI; Malech HL; DeCarlo ES; Melnick DA
J Infect Dis; 1991 Apr; 163(4):849-52. PubMed ID: 1901332
[TBL] [Abstract][Full Text] [Related]
2. Dose-dependent enhancements by interferon-gamma on functional responses of neutrophils from chronic granulomatous disease patients.
Ahlin A; Elinder G; Palmblad J
Blood; 1997 May; 89(9):3396-401. PubMed ID: 9129047
[TBL] [Abstract][Full Text] [Related]
3. Normal and deficient neutrophils can cooperate to damage Aspergillus fumigatus hyphae.
Rex JH; Bennett JE; Gallin JI; Malech HL; Melnick DA
J Infect Dis; 1990 Aug; 162(2):523-8. PubMed ID: 2165113
[TBL] [Abstract][Full Text] [Related]
4. Prolonged recombinant interferon-gamma therapy in chronic granulomatous disease: evidence against enhanced neutrophil oxidase activity.
Woodman RC; Erickson RW; Rae J; Jaffe HS; Curnutte JT
Blood; 1992 Mar; 79(6):1558-62. PubMed ID: 1312372
[TBL] [Abstract][Full Text] [Related]
5. Safety and effectiveness of long-term interferon gamma therapy in patients with chronic granulomatous disease.
Bemiller LS; Roberts DH; Starko KM; Curnutte JT
Blood Cells Mol Dis; 1995; 21(3):239-47. PubMed ID: 8673477
[TBL] [Abstract][Full Text] [Related]
6. Enhanced cutaneous inflammatory reactions to Aspergillus fumigatus in a murine model of chronic granulomatous disease.
Petersen JE; Hiran TS; Goebel WS; Johnson C; Murphy RC; Azmi FH; Hood AF; Travers JB; Dinauer MC
J Invest Dermatol; 2002 Mar; 118(3):424-9. PubMed ID: 11874480
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon.
Roilides E; Uhlig K; Venzon D; Pizzo PA; Walsh TJ
Infect Immun; 1993 Apr; 61(4):1185-93. PubMed ID: 7681040
[TBL] [Abstract][Full Text] [Related]
8. Treatment of patients with chronic granulomatous disease with recombinant human interferon-gamma does not improve neutrophil oxidative metabolism, cytochrome b558 content or levels of four anti-microbial proteins.
Mühlebach TJ; Gabay J; Nathan CF; Erny C; Dopfer G; Schroten H; Wahn V; Seger RA
Clin Exp Immunol; 1992 May; 88(2):203-6. PubMed ID: 1572085
[TBL] [Abstract][Full Text] [Related]
9. Human polymorphonuclear leukocytes inhibit Aspergillus fumigatus conidial growth by lactoferrin-mediated iron depletion.
Zarember KA; Sugui JA; Chang YC; Kwon-Chung KJ; Gallin JI
J Immunol; 2007 May; 178(10):6367-73. PubMed ID: 17475866
[TBL] [Abstract][Full Text] [Related]
10. Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus.
Morgenstern DE; Gifford MA; Li LL; Doerschuk CM; Dinauer MC
J Exp Med; 1997 Jan; 185(2):207-18. PubMed ID: 9016870
[TBL] [Abstract][Full Text] [Related]
11. Exogenous Stimulation of Type I Interferon Protects Mice with Chronic Granulomatous Disease from Aspergillosis through Early Recruitment of Host-Protective Neutrophils into the Lung.
Seyedmousavi S; Davis MJ; Sugui JA; Pinkhasov T; Moyer S; Salazar AM; Chang YC; Kwon-Chung KJ
mBio; 2018 Mar; 9(2):. PubMed ID: 29588403
[TBL] [Abstract][Full Text] [Related]
12. Human Neutrophils Use Different Mechanisms To Kill Aspergillus fumigatus Conidia and Hyphae: Evidence from Phagocyte Defects.
Gazendam RP; van Hamme JL; Tool AT; Hoogenboezem M; van den Berg JM; Prins JM; Vitkov L; van de Veerdonk FL; van den Berg TK; Roos D; Kuijpers TW
J Immunol; 2016 Feb; 196(3):1272-83. PubMed ID: 26718340
[TBL] [Abstract][Full Text] [Related]
13. Genes differentially expressed in conidia and hyphae of Aspergillus fumigatus upon exposure to human neutrophils.
Sugui JA; Kim HS; Zarember KA; Chang YC; Gallin JI; Nierman WC; Kwon-Chung KJ
PLoS One; 2008 Jul; 3(7):e2655. PubMed ID: 18648542
[TBL] [Abstract][Full Text] [Related]
14. Restoration of anti-Aspergillus defense by neutrophil extracellular traps in human chronic granulomatous disease after gene therapy is calprotectin-dependent.
Bianchi M; Niemiec MJ; Siler U; Urban CF; Reichenbach J
J Allergy Clin Immunol; 2011 May; 127(5):1243-52.e7. PubMed ID: 21376380
[TBL] [Abstract][Full Text] [Related]
15. Damage to Aspergillus fumigatus and Rhizopus oryzae hyphae by oxidative and nonoxidative microbicidal products of human neutrophils in vitro.
Diamond RD; Clark RA
Infect Immun; 1982 Nov; 38(2):487-95. PubMed ID: 6292103
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of destruction of Aspergillus fumigatus hyphae mediated by human monocytes.
Diamond RD; Huber E; Haudenschild CC
J Infect Dis; 1983 Mar; 147(3):474-83. PubMed ID: 6300255
[TBL] [Abstract][Full Text] [Related]
17. Aspergillus osteomyelitis in a child who has p67-phox-deficient chronic granulomatous disease.
Tsumura N; Akasu Y; Yamane H; Ikezawa S; Hirata T; Oda K; Sakata Y; Shirahama M; Inoue A; Kato H
Kurume Med J; 1999; 46(1):87-90. PubMed ID: 10319618
[TBL] [Abstract][Full Text] [Related]
18. Chronic granulomatous disease.
Dinauer MC; Orkin SH
Annu Rev Med; 1992; 43():117-24. PubMed ID: 1316094
[TBL] [Abstract][Full Text] [Related]
19. Interferon-gamma in the treatment of the chronic granulomatous diseases of childhood.
Gallin JI
Clin Immunol Immunopathol; 1991 Nov; 61(2 Pt 2):S100-5. PubMed ID: 1934607
[TBL] [Abstract][Full Text] [Related]
20. Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon.
Roilides E; Uhlig K; Venzon D; Pizzo PA; Walsh TJ
Infect Immun; 1993 Nov; 61(11):4870-7. PubMed ID: 7691757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
